Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2008 | 4 |
2010 | 1 |
2024 | 0 |
Search Results
5 results
Results by year
Filters applied: . Clear all
Page 1
Bevacizumab, sorafenib tosylate, sunitinib and temsirolimus for renal cell carcinoma: a systematic review and economic evaluation.
Health Technol Assess. 2010 Jan;14(2):1-184, iii-iv. doi: 10.3310/hta14020.
Health Technol Assess. 2010.
PMID: 20028613
Free article.
Review.
Temsirolimus in metastatic renal cell carcinoma.
Négrier S.
Négrier S.
Ann Oncol. 2008 Aug;19(8):1369-1370. doi: 10.1093/annonc/mdn373. Epub 2008 May 25.
Ann Oncol. 2008.
PMID: 18504249
Free article.
No abstract available.
Item in Clipboard
Temsirolimus safety profile and management of toxic effects in patients with advanced renal cell carcinoma and poor prognostic features.
Bellmunt J, Szczylik C, Feingold J, Strahs A, Berkenblit A.
Bellmunt J, et al.
Ann Oncol. 2008 Aug;19(8):1387-1392. doi: 10.1093/annonc/mdn066. Epub 2008 Apr 2.
Ann Oncol. 2008.
PMID: 18385198
Free article.
Clinical Trial.
Item in Clipboard
mTORC1 inhibitors: is temsirolimus in renal cancer telling us how they really work?
Le Tourneau C, Faivre S, Serova M, Raymond E.
Le Tourneau C, et al.
Br J Cancer. 2008 Oct 21;99(8):1197-203. doi: 10.1038/sj.bjc.6604636. Epub 2008 Sep 16.
Br J Cancer. 2008.
PMID: 18797463
Free PMC article.
Review.
Item in Clipboard
Temsirolimus, an inhibitor of mammalian target of rapamycin.
Rini BI.
Rini BI.
Clin Cancer Res. 2008 Mar 1;14(5):1286-90. doi: 10.1158/1078-0432.CCR-07-4719.
Clin Cancer Res. 2008.
PMID: 18316545
Review.
No abstract available.
Item in Clipboard
Cite
Cite